RxDoctor Payments Data

April Ross

Family · Grand Junction, CONPI 1487960092

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $87,995 of the $94,574 with a category attached, or 93.0%. AbbVie accounts for 72.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $69,242 and has fallen 99.7% since, to $241 in 2025. Among family clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$94,574in general payments, 2019–2025

Across 229 payments — averaging $412.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$69K
  • Biohaven Pharmaceuticals, Inc.$20K
  • Biohaven Pharmaceutical Holding Company Ltd.$3K
  • Merz North America, Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$573
  • Amgen$190
  • plus $546 from 16 others

What the payments were for

  • Speaking & faculty fees$87,99593%
  • Travel & lodging$1,7262%
  • Food & beverage$4,8535%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$94,574 in reported general payments places this provider in the 95th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Other family in Grand Junction

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →